CSIMarket
 
Anika Therapeutics Inc   (ANIK)
Other Ticker:  
 

Anika Therapeutics Inc

Business Description


Anika Therapeutics Inc is a global medical technology company that specializes in tissue-medical devices for the regenerative treatment of pain and musculoskeletal conditions. The company is headquartered in Bedford, Massachusetts, USA, and operates in over 30 countries worldwide.

Anika Therapeutics Inc was founded in 1992 by Charles H. Sherwood, Ph.D., and Richard G. Steadman, M.D, with a vision to create and deliver products that could help to promote the healing and recovery of individuals suffering from musculoskeletal injuries or diseases. The company has since grown to become a leading provider of advanced medical devices and therapies, using a range of technologies developed in-house.

The company*s core product offering includes a number of tissue implants, including Orthovisc, Monovisc, and Cingal, which are designed to help alleviate the pain and mobility issues experienced by patients with osteoarthritis. These devices, which are made using high-purity hyaluronic acid, are injected into the joint to lubricate and cushion the affected area, providing long-lasting relief.

In addition to these products, Anika Therapeutics Inc also offers a range of other medical devices and solutions, such as the AmnioExcel amniotic membrane product, which is used in wound healing, and the Hyalofast scaffold, which allows for the delivery of cells and growth factors in tissue engineering repair applications.

Anika Therapeutics Inc is proud of its commitment to quality and innovation, investing heavily in research and product development to improve the efficacy and range of its medical solutions. The company has a strong record of innovation, having filed over 100 patents to date, and regularly collaborates with leading medical institutions and industry partners to develop and improve its products.

Overall, Anika Therapeutics Inc offers a diverse range of innovative, high-quality medical solutions designed to address a range of musculoskeletal concerns, improving patient outcomes and quality of life. Its focus on quality, innovation, and collaboration has helped establish it as a leader in the industry, and it continues to grow and expand its product offerings to address the evolving needs of patients worldwide.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com